Acetaminophen Extended Release Tablets 650 mg

Manufacturer
Bi-Mart | Granules India Limited
Effective date
2025-03-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:57:38

Label at a glance#

ProductACETAMINOPHEN
Active ingredientACETAMINOPHEN
Label structure15 sections

Indications and uses

• temporarily relieves minor aches and pains due to:     • minor pain of arthritis     • muscular aches     • backache     • premenstrual and menstrual cramps     • the common cold     • headache     • toothache • temporarily reduces fever

Dosage and administration

•  do not take more than directed (see overdose warning)  adults  • take 2 caplets every 8 hours with water  • swallow whole; do not crush, chew, split or dissolve  • do not take more than 6 caplets in 24 hours  • do not use for more than 10 days unless directed by a doctor   under 18 years  of age  • ask a doctor

Label contents#

Full prescribing information#

ACTIVE INGREDIENT (IN EACH CAPLET)

OTC - ACTIVE INGREDIENT SECTION

Acetaminophen  650 mg

PURPOSE

OTC - PURPOSE SECTION

Pain reliever/fever reducer

USES

INDICATIONS & USAGE SECTION

• temporarily relieves minor aches and pains due to:
    • minor pain of arthritis
    • muscular aches
    • backache
    • premenstrual and menstrual cramps
    • the common cold
    • headache
    • toothache
• temporarily reduces fever

WARNINGS

WARNINGS SECTION

Liver warning:This product contains acetaminophen. Severe Liver damage may occur if you take
• more than 6 caplets in 24 hours, which is the maximum daily amount
• with other drugs containing acetaminophen
• 3 or more alcoholic drinks everyday while using this product

Allergy alert:acetaminophen may cause severe skin reactions
Symptoms may include:
• skin reddening
• blisters 
• rash
If a skin reaction occurs, stop use and seek medical help right away

Do not use

OTC - DO NOT USE SECTION

• with any other drugs containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
• if you are allergic to acetaminophen or any of the inactive ingredients in this product.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

liver disease.

Ask a doctor or pharmacist before use if you are 

OTC - ASK DOCTOR/PHARMACIST SECTION

taking the blood thinning drug warfarin.

Stop use and ask doctor if

OTC - STOP USE SECTION

  • pain gets worse or lasts more than 10 days
  • fever gets worse or lasts more than 3 days
  • new symptoms occur
  • redness or swelling is present
These could be signs of a serious condition.

If pregnant or breast-feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Overdose warning:In case of overdose, get medical help or contact a Poison Control Center (1-800 222-1222) right away.  Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

•  do not take more than directed (see overdose warning)

 adults • take 2 caplets every 8 hours with water
 • swallow whole; do not crush, chew, split or dissolve
 • do not take more than 6 caplets in 24 hours
 • do not use for more than 10 days unless directed by a doctor 
 under 18 years
 of age
 • ask a doctor

OTHER INFORMATION

SPL UNCLASSIFIED SECTION

• store between 20-25°C (68-77°F)
• DO NOT USE IF PRINTED SEAL UNDER CAP IS MISSING OR DAMAGED.

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

hydroxyethyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, pregelatinized starch, sodium starch glycolate, stearic acid

QUESTIONS ?

OTC - QUESTIONS SECTION

call toll free 1-844-912-4012

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 37835-512-01

Compare to the active ingredients in Tylenol ® 8 HR Arthritis Pain*

Acetaminophen Extended-release Tablets

650 mg

Pain reliever/fever reducer

For the Temporary Relief of Minor Arthritis Pain

100 Caplets

*This product is not manufactured or distributed by the owner of the registered trademark Tylenol ® 8 HR Arthritis Pain.

Distributed by:

BI-MART

Eugene, OR 97402

labellabel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1148399acetaminophen 650 MG 8HR Extended Release Oral TabletPSN1
11483998 HR acetaminophen 650 MG Extended Release Oral TabletSCD1
11483998 HR APAP 650 MG Extended Release Oral TabletSY1
1148399acetaminophen 650 MG 8 HR Extended Release Oral TabletSY1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
37835-512-01ACETAMINOPHEN100 in 1 BOTTLETABLET, EXTENDED RELEASE1001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
37835-512ACETAMINOPHEN TABLET, EXTENDED RELEASE [BI-MART]11 package rows20250323_ab2f0834-bdef-4862-b549-5a8161f8420b.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
37835-51237835-512-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
30d44923-02f8-c4ea-e063-6294a90a935aab2f0834-bdef-4862-b549-5a8161f8420b2025-03-01WarningsExact identifier
spl id: 30d44923-02f8-c4ea-e063-6294a90a935a
spl set id: ab2f0834-bdef-4862-b549-5a8161f8420b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.